跳至主要内容
临床试验/PACTR201808609844917
PACTR201808609844917尚未招募未知

From Directly-Observed Therapy (DOT) to Digital Adherence Technology (DAT) for TB Treatment

niversity of California San Francisco0 个研究点目标入组 3,060 人开始时间: 2018年8月30日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
3,060

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 Day(s) 至 1 Month(s)(—)
性别
All

入选标准

  • •Site-level Inclusion Criteria: 1. Diagnosed >10 PTB patients/month in 2017; 2. Not located within Kampala District; 3. Located within 225km of Kampala city; 4. PTB treatment success rate in 2016 of <80%
  • •Patient-level Inclusion Criteria: 1. Initiating Category I treatment for active pulmonary TB at a study facility during the study period

排除标准

  • •Site-level Exclusion Criteria: 1. Do not agree to participate in the trial
  • •Patient-level Exclusion Criteria: 1. Diagnosed with extra-pulmonary TB; 2. Diagnosed with or referred for evaluation of drug-resistant TB; 3. Does not own a mobile phone with SMS capabilities

研究者

发起方
niversity of California San Francisco

相似试验